Ondansetron Dosing for a 32.32 kg Child
For a child weighing 32.32 kg, administer ondansetron 4 mg orally three times daily for chemotherapy-induced nausea/vomiting, or 0.15 mg/kg (approximately 5 mg) as a single dose for acute gastroenteritis or postoperative nausea/vomiting.
Context-Specific Dosing
For Chemotherapy-Induced Nausea and Vomiting
The FDA-approved dosing for moderately emetogenic chemotherapy in pediatric patients 4-11 years of age is 4 mg orally three times daily 1. The first dose should be given 30 minutes before chemotherapy, with subsequent doses at 4 and 8 hours after the first dose, then every 8 hours for 1-2 days after chemotherapy completion.
- Weight consideration: At 32.32 kg, this child likely falls into the 4-11 year age range where 4 mg TID is the standard dose
- If the child is ≥12 years old, use the adult dose of 8 mg twice daily 1
For Acute Gastroenteritis
Administer 0.15 mg/kg as a single oral dose, which equals approximately 5 mg for this 32.32 kg child 2, 3, 4. Research demonstrates that:
- A single dose of 0.1 mg/kg effectively reduces vomiting in gastroenteritis 2
- Doses ranging from 0.13-0.26 mg/kg show similar efficacy without increased side effects 5
- The 0.15 mg/kg dose is optimal based on multiple high-quality studies 3, 4
The most recent 2025 trial showed that multidose ondansetron (up to 6 doses over 48 hours) reduced moderate-to-severe gastroenteritis compared to placebo 3, though single-dose efficacy remains well-established for immediate symptom control 4.
For Postoperative Nausea and Vomiting
Use 0.1-0.15 mg/kg intravenously (approximately 3-5 mg) as a single dose 6, 7. Research shows:
- 0.15 mg/kg is more effective than 0.075 mg/kg for preventing post-tonsillectomy vomiting 8
- Doses of 0.1-0.15 mg/kg IV are superior to other antiemetics like droperidol or metoclopramide 7
For Radiation-Induced Nausea and Vomiting
The FDA label does not provide pediatric dosing for radiation therapy 1. Adult dosing is 8 mg orally three times daily, but there is no established pediatric experience in this indication.
Important Caveats
Avoid exceeding maximum doses: The FDA label emphasizes no experience with 24 mg dosing in pediatric patients 1. For this 32.32 kg child, single doses should not exceed 8 mg.
Hepatic impairment: If severe hepatic dysfunction is present (Child-Pugh ≥10), do not exceed 8 mg total daily dose 1.
Formulation flexibility: Ondansetron is available as tablets, orally disintegrating tablets (ODT), and oral soluble films—all bioequivalent. ODTs dissolve on the tongue without water, useful for vomiting children 1.
Diarrhea consideration: Ondansetron does not increase diarrhea episodes in the dose range of 0.13-0.26 mg/kg 5, addressing a common clinical concern.